The Diagnostic and Prognostic Value of Bone Marrow Immunostaining in Myelodysplastic Syndromes

References

• Kitagawa M., Kamiyama R., Takemura T., Kasuga T. Bone marrow analysis of the myelodysplasia syndromes: histological and immunohistochemical features related to the evolution of overt leukemia. Virchows Arch. B: Cell. Pathol 1989; 57: 47–53
   Google Scholar
• Sultan C., Sigaux F., Imbert M., Reyes F. Acute myelodysplasia with myelofibrosis: a report of eight cases. Br. J. Haematol. 1981; 49: 11–16
   PubMed Web of Science ®Google Scholar
• Pagliuca A., Layton D. M., Manoharan A., Gordon S., Green P. J., Mufti Gℑ. Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of ten cases. Br. J. Haematol. 1989; 71: 499–504
   PubMed Web of Science ®Google Scholar
• Lambertenghi Deliliers G., Orazi A., Luksch R., Annaloro C., Soligo D. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br. J. Haemarol. 1991; 78: 161–166
   PubMed Web of Science ®Google Scholar
• Tricot G., De Wolf-Peters C., Vlientinck R., Verwilghen R. L. Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS. Br. J. Haemarol. 1984; 58: 217–225
   PubMed Web of Science ®Google Scholar
• Lambertenghi-Deliliers G., Annaloro C., Oriani A., Soligo D., Pozzoli E., Polli E. E. Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes. Annals of Hemarol. 1993; 66: 85–91
   Web of Science ®Google Scholar
• Kitagawa M., Kamiyama R., Kasuga T. Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia. Hum. Parhol. 1993; 24: 359–363
   PubMed Web of Science ®Google Scholar
• Verhoef G. E. G., De Wolf-Peeters C., Ferrant A., Deprez S., Meeus P., Stul M., Zachee P., Cassiman J. J., Van den Berghe H., Boogaerts M. A. Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann. Hematol. 1991; 63: 235–241
   PubMed Web of Science ®Google Scholar
• Cordell J. L., Falini B., Erber W. N., Ghoshak A. K., Zainalabidden A., MacDonald S., Pulford K. A. F., Stein H., Mason D. Y. lmmunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Hisrochem. Cvrochem. 1984; 32: 219–229
   PubMed Web of Science ®Google Scholar
• Mangi M. H., Mufti G. J. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. Blood 1992; 79: 198–205
   PubMed Web of Science ®Google Scholar
• Elghetany M. T., Sullivan A. K., Kurec A. S., MacCallum J. M., Bloomfield C. D., Sobol R. E., Davey F. R. The use of monoclonal antibodies against primary myeloid granules in normal and leukemic cells. Am. J. Clin. Pathol. 1992; 98: 430–436
   PubMed Web of Science ®Google Scholar
• Orazi A., Cattoretti G., Soligo D., Luksch R., Lambertenghi Deliliers G. Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment. Leukemia 1993; 7: 838–847
   PubMed Web of Science ®Google Scholar
• Delia D., Aiello A., Soligo D., Fontanella E., Melani C., Pezzella F., Pierotti M. A., Delia Porta G. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 1992; 79: 1291–1298
   PubMed Web of Science ®Google Scholar
• Titius B. R., Thiele J., Schaefer H., Kreipe H., Fischer R. Ki-S1 and proliferating cell nuclear antigen expression of bone marrow macrophages. Immunohistochemical and morphometric study including reactive (inflammatory) myelitis, secondary aplastic anemia, Aids, myelodysplastic syndromes and primary (idiopathic) osteomyelofibrosis. Ada Haematol 1994; 91: 144–149
   PubMedGoogle Scholar
• Werner M., Kaloutsi V., Walter K., Buhr T., Bemhards J., Georgii A. Immunohistochemical examination of routinely processed bone marrow biopsies. Pathol Res. Pract. 1992; 188: 707–713
   PubMed Web of Science ®Google Scholar
• Weber-Matthiesen K., Deerberg J., Poetsch M., Grote W., Schlegelberger B. Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 1995; 86: 1464–1468
   PubMed Web of Science ®Google Scholar
• Guyotat D., Campos L., Thomas X., Vila L., Shi Z., Charrin C., Gentilhomme O., Fiere D. Myelodysplastic syndromes: a study of surface markers and in vitro growth patterns. Am. J. Hematoi 1990; 34: 26–31
   PubMed Web of Science ®Google Scholar
• Seo I. S., Li C. Y., Yam L. T. Myelodysplastic syndrome: diagnostic implications of cytochemical and immunocytochemical studies. Mayo Clin. Proc 1993; 68: 47–53
   PubMed Web of Science ®Google Scholar
• Felzmann T., Gisslinger H., Ludwig H. Immunologic findings in patients with myelodysplastic syndrome. Leukemia and Lymphoma 1994; 15: 201–208
   PubMed Web of Science ®Google Scholar
• Keim D. R., Hanash S. M. Proliferating cell nuclear antigen; a new marker of proliferation in cancer. Leukemia and Lymphoma 1992; 6: 459–468
   Web of Science ®Google Scholar
• Thiele J., Quitmann H., Wagner S., Fischer R. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens. J. Clin. Pathol. 1991; 44: 300–305
   PubMed Web of Science ®Google Scholar
• Thiele J., Titius B. R., Kopsidis C., Fischer R. Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts: a critical evaluation by immunohistochem-istry, cytochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes. Virchows Arch. B: Cell. Pathol. Incl. Mol. Pathol 1992; 62: 275–282
   PubMedGoogle Scholar
• Thiele J., Titius B. R., Quitmann H., Fischer R., Salzberger B., Dienemann D., Stein H. Megakaryocytopoiesis in bone marrow biopsies of patients with acquired immunodeficiency syndrome (Aids). An immunohistochemical and morphometric evaluation with special emphasis on myelodysplastic features and precursor cells. Pathol. Res. Pract. 1992; 188: 722–728
   PubMed Web of Science ®Google Scholar
• Thiele J., Hoffmann I., Bertsch H. P., Fischer R. Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes. Virchows Arch. A: Pathol. Anat. Histopathol 1993; 423: 33–38
   PubMedGoogle Scholar
• Maschek H., Georgii A., Kaloutsi V., Werner M., Bandecar K., Kressel M. G., Choritz H., Freund M., Hufhagl D. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. Eur. J. Haematol 1992; 48: 208–214
   PubMed Web of Science ®Google Scholar
• Hockenbery D. M., Zutter M., Hickey W., Nahm M., Korsmeyer S. J. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 6961–6965
   PubMed Web of Science ®Google Scholar
• Eastman A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 1990; 2: 275–280
   PubMed Web of Science ®Google Scholar
• Lepelley P., Preudhomme C., Vanrumbeke M., Quesnel B., Cosson A., Fenaux P. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia 1994; 8: 1342–1349
   PubMed Web of Science ®Google Scholar
• Kitagawa M., Yoshida S., Kuwata T., Tanizawa T., Kamiyama R. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia. Am. J. Pathol 1994; 145: 338–344
   PubMed Web of Science ®Google Scholar
• Orazi A., Cattoretti G., Heerema N. A., Sozzi G., John K., Neiman R. S. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies. Mod. Pathol 1993; 6: 521–525
   PubMed Web of Science ®Google Scholar
• Zhou D., Marie J. P., Suberville A. M., Zittoun R. Relevance of mdrl gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia 1992; 6: 879–885
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Calmard-Oriol P., Tsuruo T., Troncy J., Treille D., Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992; 79: 473–476
   PubMed Web of Science ®Google Scholar
• te Boekhorst P. A., de Leeuw K., Schoester M., Wittebol S., Nooter K., Hagemeijer A., Lowenberg B., Sonneveld P. Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood 1993; 82: 3157–3162
   PubMed Web of Science ®Google Scholar
• Lepelley P., Soenen V., Preudhomme C., Lai J. L., Cosson A., Fenaux P. Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes. Leukemia 1994; 8: 998–1004
   PubMed Web of Science ®Google Scholar
• McCormick D., Hall P. The complexities of proliferating cell nuclear antigen. Histopathology 1992; 21: 591–594
   PubMed Web of Science ®Google Scholar
• Soligo D., Delia D., Oriani A., Cattoretti G., Orazi A., Bertolli V., Quirici N., Lambertenghi Deliliers G. Identification of CD34+ in normal and pathological bone marrow biopsies by Qbend10 monoclonal antibody. Leukemia 1991; 5: 1026–1030
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Gockerman J. P., Moore J. O., Civin C., Page S. O., Robertson J., Bigner S. H. Clinicopathologic and cytogenetic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. Am. J. Clin. Pathol 1989; 91: 265–270
   PubMed Web of Science ®Google Scholar
• Geller R. B., Zahurak M., Hurwitz C. A., Burke P. J., Karp J. E., Piantadosi S., Civin C. I. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of stem-cell glycoprotein CD34 (MY 10). Br. J. Haematol 1990; 76: 340–347
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Devaux Y., Treille D., Larese A., Maupas J., Gentilhomme O., Ehrsam A., Fiere D. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy. Br. J. Haematol 1989; 72: 161–166
   PubMed Web of Science ®Google Scholar
• Sperling C., Büchner T., Creutzig U., Ritter J., Harbott J., Fonatsch C., Sauerland C., Mielcarek M., Maschmeyer G., Löffler H., Wolf-Dieter L. Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML. Leukemia and Lymphoma 1995; 17: 417–426
   PubMed Web of Science ®Google Scholar
• Sullivan S. A., Marsden K. A., Lowenthal R. M., Jupe D. M., Jones M. E. Circulating CD34+ cells: an adverse prognostic factor in the myelodysplastic syndromes. Am. J. Hematoi. 1992; 39: 96–101
   PubMed Web of Science ®Google Scholar
• Oertel J., Oertel B., Beyer J., Huhn D. CD34 immunotyping of blasts in myelodysplasia. Ann. Hematoi 1994; 68: 77–80
   PubMed Web of Science ®Google Scholar
• Sawada K. I. Impaired Proliferation and differentiation of myelodysplastic CD34+ cells. Leukemia and Lymphoma 1994; 14: 37–47
   PubMed Web of Science ®Google Scholar
• Sawada K., Sato N., Notoya A., Tarumi T., Hirayama S., Takano H., Koizumi K., Yasukouchi T., Yamaguchi M., Koike T. Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells. Blood 1995; 85: 194–202
   PubMed Web of Science ®Google Scholar
• Soligo D. A., Oriani A., Annaloro C., Cortelezzi A., Calori R., Pozzoli E., Nosella D., Orazi A., Lambertenghi Deliliers G. CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes. Am. J. Hematol. 1994; 46: 9–17
   PubMed Web of Science ®Google Scholar
• Oriani A., Annaloro C., Soligo D., Pozzoli E., Cortelezzi A., Lambertenghi Deliliers G. Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes. Br. J. Haematol. 1996; 92: 360–364
   PubMed Web of Science ®Google Scholar